Publikationen von Norman Hackl

von Au, A.; Vasel, M.; Kraft, S.; Sens, C.; Hackl, N.; Marx, A.; Stroebel, P.; Hennenlotter, J.; Todenhoefer, T.; Stenzl, A. et al.; Schott, S.; Sinn, H.-P.; Wetterwald, A.; Bermejo, J. L.; Cecchini, M. G.; Nakchbandi, I. A.: Circulating Fibronectin Controls Tumor Growth. NEOPLASIA 15 (8), S. 925 - 938 (2013)

Hackl, N.; von Au, A.; Vasel, M.; Tiwari, S.; Cecchini, M. G.; Nakchbandi, I. A.: The role of fibronectin in the bone marrow metastatic niches. Bone 47 (Suppl. 2), S. S263 - S264 (2010)

Hackl, N. J.; Bersch, C.; Feick, P.; Antoni, C.; Franke, A.; Singer, M. V.; Nakchbandi, I. A.: Circulating fibronectin isoforms predict the degree of fibrosis in chronic hepatitis C. Scandinavian Journal of Gastroenterology 45 (3), S. 349 - 356 (2010)

Kawelke, N.; Bentmann, A.; Hackl, N.; Hager, H. D.; Feick, P.; Geursen, A.; Singer, M. V.; Nakchbandi, I. A.: Isoform of fibronectin mediates bone loss in patients with primary biliary cirrhosis by suppressing bone formation. Journal of Bone and Mineral Research 23 (8), S. 1278 - 1286 (2008)

Kawelke, N.; Bentmann, A.; Hackl, N.; Nakchbandi, I. A.: Bone loss in patients with primary biliary cirrhosis is caused by a fibronectin isoform. Calcified Tissue International 82 (Suppl. Suppl. 1), S. S106 - S106 (2008)